ProShare Advisors’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$65.8K Buy
31,493
+6,106
+24% +$12.8K ﹤0.01% 1955
2025
Q1
$43.3K Sell
25,387
-5,465
-18% -$9.32K ﹤0.01% 1966
2024
Q4
$156K Buy
30,852
+7,188
+30% +$36.3K ﹤0.01% 1961
2024
Q3
$129K Buy
23,664
+8,110
+52% +$44.1K ﹤0.01% 1844
2024
Q2
$74.7K Sell
15,554
-2,708
-15% -$13K ﹤0.01% 1699
2024
Q1
$56.8K Buy
18,262
+1,509
+9% +$4.69K ﹤0.01% 1889
2023
Q4
$47.6K Buy
16,753
+2,036
+14% +$5.78K ﹤0.01% 1867
2023
Q3
$43.1K Buy
14,717
+67
+0.5% +$196 ﹤0.01% 1727
2023
Q2
$41.9K Buy
14,650
+582
+4% +$1.67K ﹤0.01% 1787
2023
Q1
$43.5K Sell
14,068
-2,025
-13% -$6.26K ﹤0.01% 1683
2022
Q4
$34K Buy
16,093
+5,483
+52% +$11.6K ﹤0.01% 1771
2022
Q3
$34K Buy
10,610
+606
+6% +$1.94K ﹤0.01% 1690
2022
Q2
$32K Sell
10,004
-656
-6% -$2.1K ﹤0.01% 1747
2022
Q1
$75K Sell
10,660
-3,846
-27% -$27.1K ﹤0.01% 2076
2021
Q4
$105K Buy
+14,506
New +$105K ﹤0.01% 2195